1. Home
  2. STEC vs VVOS Comparison

STEC vs VVOS Comparison

Compare STEC & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STEC
  • VVOS
  • Stock Information
  • Founded
  • STEC 2006
  • VVOS 2016
  • Country
  • STEC China
  • VVOS United States
  • Employees
  • STEC N/A
  • VVOS N/A
  • Industry
  • STEC
  • VVOS Medical Specialities
  • Sector
  • STEC
  • VVOS Health Care
  • Exchange
  • STEC NYSE
  • VVOS Nasdaq
  • Market Cap
  • STEC 19.0M
  • VVOS 18.5M
  • IPO Year
  • STEC 2021
  • VVOS 2020
  • Fundamental
  • Price
  • STEC $1.37
  • VVOS $2.53
  • Analyst Decision
  • STEC
  • VVOS Strong Buy
  • Analyst Count
  • STEC 0
  • VVOS 2
  • Target Price
  • STEC N/A
  • VVOS $6.30
  • AVG Volume (30 Days)
  • STEC 42.5K
  • VVOS 79.1K
  • Earning Date
  • STEC 04-08-2025
  • VVOS 03-31-2025
  • Dividend Yield
  • STEC N/A
  • VVOS N/A
  • EPS Growth
  • STEC N/A
  • VVOS N/A
  • EPS
  • STEC N/A
  • VVOS N/A
  • Revenue
  • STEC $260,474,693.00
  • VVOS $15,031,000.00
  • Revenue This Year
  • STEC $9.76
  • VVOS $12.35
  • Revenue Next Year
  • STEC $15.85
  • VVOS $26.02
  • P/E Ratio
  • STEC N/A
  • VVOS N/A
  • Revenue Growth
  • STEC N/A
  • VVOS 8.91
  • 52 Week Low
  • STEC $0.20
  • VVOS $1.91
  • 52 Week High
  • STEC $3.25
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • STEC 45.61
  • VVOS 30.17
  • Support Level
  • STEC $1.21
  • VVOS $2.38
  • Resistance Level
  • STEC $1.35
  • VVOS $3.36
  • Average True Range (ATR)
  • STEC 0.11
  • VVOS 0.29
  • MACD
  • STEC -0.04
  • VVOS -0.08
  • Stochastic Oscillator
  • STEC 12.12
  • VVOS 13.30

About STEC SANTECH HOLDINGS LIMITED

Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: